GHK-Cu
Synthetic peptide studied in animal and cell models for unprecedented gene modulation and collagen & skin regeneration
Last updated: March 1, 2026
- Compound
- GHK-Cu
- Class
- Recovery peptide
- Summary
- Synthetic peptide studied in animal and cell models for unprecedented gene modulation, collagen & skin regeneration, scarless healing promotion.
- Mechanism
- Stem Cell Activation & Tissue Renewal
- Research Status
- Phase I
- Routes Studied
- Subcutaneous injection or topical application
- Evidence Level
- Early-stage research · Clinically unproven
What Should You Know About GHK-Cu?
- What is GHK-Cu?
- GHK-Cu is a synthetic peptide studied in animal and cell models for unprecedented gene modulation and collagen & skin regeneration.
- Is GHK-Cu clinically proven?
- No. Human evidence remains limited and does not establish GHK-Cu as clinically proven. See the full evidence review for a study-by-study breakdown.
- What has GHK-Cu been studied for?
- GHK-Cu has been studied in preclinical models of unprecedented gene modulation, collagen & skin regeneration, scarless healing promotion. These findings have not been confirmed in large-scale human trials.
- Is GHK-Cu approved?
- No. GHK-Cu is not an approved drug and remains a research compound.
What Is GHK-Cu?
GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) is a naturally occurring tripeptide with the sequence Gly-His-Lys that possesses a strong affinity for copper(II) ions. First identified in human plasma by Dr. Loren Pickart in 1973, GHK-Cu was isolated from albumin and found to be present in blood plasma, saliva, and urine. Pickart discovered that old human plasma, depleted of GHK-Cu, produced liver cells that synthesized fibrinogen at rates typical of old tissue, while...
Evidence Summary
GHK-Cu has early-stage clinical data only. Safety data is emerging but efficacy evidence remains limited. Most claims exceed current clinical evidence.
Evidence Breakdown
| Domain | Evidence Level |
|---|---|
| Unprecedented Gene Modulation | Limited |
| Collagen & Skin Regeneration | Limited |
| Scarless Healing Promotion | Limited |
| Antioxidant & Anti-Inflammatory | Limited |
| Human clinical evidence | Limited |
| Safety data | Insufficient |
| Deep Research Score | 2.0 / 5 See full review |
Editorial Position
GHK-Cu is best understood as a preclinical research compound with promising biological signals but limited human validation. Many online claims exceed the strength of available human evidence, and safety data remains incomplete. Any consideration of this compound should involve careful evaluation of individual context and medical guidance.
Regulatory Status Snapshot
- Not approved as a therapeutic drug by major regulators
- Safety profile not established in large human populations
Need help interpreting this evidence for your situation?
Talk to a SpecialistWant the Full Scientific Evidence Review?
View the full scientific evidence review of GHK-Cu with study-by-study analysis, evidence strength ratings, and independent editorial verdicts.
View full scientific evidence review of GHK-CuWhat Has GHK-Cu Been Studied For?
Research areas where GHK-Cu has been investigated in published studies
-
Unprecedented Gene Modulation GHK-Cu has been studied in animal models of unprecedented gene modulation. These findings have not been confirmed in controlled human trials.
-
Collagen & Skin Regeneration GHK-Cu has been studied in animal models of collagen & skin regeneration. These findings have not been confirmed in controlled human trials.
-
Scarless Healing Promotion GHK-Cu has been studied in animal models of scarless healing promotion. These findings have not been confirmed in controlled human trials.
-
Antioxidant & Anti-Inflammatory GHK-Cu has been studied in animal models of antioxidant & anti-inflammatory. These findings have not been confirmed in controlled human trials.
How Does GHK-Cu Work?
These mechanisms have been observed in preclinical models. They are plausible but have not been linked to proven clinical outcomes in humans.
- 01 Copper Delivery to Enzyme Systems
- 02 Massive Gene Expression Modulation
- 03 Collagen & Decorin Synthesis
- 04 TGF-β Isoform Switching
Not sure if GHK-Cu is right for you?
A specialist can review the evidence, evaluate your medical context, and help you make an informed decision about GHK-Cu.
Community Reports (Anecdotal)
Experiences shared here are self-reported and do not represent clinical evidence.
Rate GHK-Cu
How Is GHK-Cu Administered?
GHK-Cu is available via Subcutaneous injection or topical application, auto-injector pen. Appropriate use and protocol should be determined by a qualified specialist.
What Are the Specifications of GHK-Cu?
What Conditions Has GHK-Cu Been Linked To?
Have Questions About GHK-Cu?
Yes, GHK-Cu has documented benefits through both routes of administration. Topical application has clinical evidence for skin rejuvenation, wound healing, and cosmetic improvement. Systemic (subcutaneous) administration provides broader tissue repair and anti-aging effects through gene modulation across multiple organ systems.
Plasma GHK-Cu levels decline from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60, a 60% reduction. This decline parallels the loss of regenerative capacity observed in aging tissues, suggesting GHK-Cu depletion contributes to reduced tissue repair.
Published studies on GHK-Cu can be found on PubMed and other peer-reviewed databases. Our references section below lists key citations.
Ready to discuss GHK-Cu with a specialist?
Get evidence-based guidance tailored to your health goals and medical context.
Book a Consultation Free initial consultation. No obligation.Reviewed by the Peptide Science Thailand Editorial Team.
Last reviewed: March 1, 2026